Dissecting The Interplay of GM-CSF and Neutrophils In IgG and IgA Responses
剖析 GM-CSF 和中性粒细胞在 IgG 和 IgA 反应中的相互作用
基本信息
- 批准号:8198166
- 负责人:
- 金额:$ 64.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-07 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdjuvantAffinityAntigensAvidityB-Lymphocyte SubsetsB-LymphocytesCellsCellular biologyDNADataEpitopesFrequenciesGenerationsGenesGoalsGranulocyte-Macrophage Colony-Stimulating FactorHIVHIV vaccineHomingImmuneImmunizationImmunoglobulin AImmunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin MImmunoglobulin Switch RecombinationInstructionIntestinesLigandsLymphocyteLymphoidMemory B-LymphocyteModelingModified Vaccinia Virus AnkaraOrganPathway interactionsPrevention strategyRecombinantsResearchResourcesRoleSIVSurfaceT cell responseTropismVaccinesVirionVirusVirus-like particlecytokineimmunogenicityimprovedmonomermucosal sitenanoparticleneutralizing antibodyneutrophilnovelreceptorresponse
项目摘要
The goal of this proposal is to elucidate the mechanisms by which the adjuvant GM-CSF enhances vaccineinduced
IgG and IgA responses against SIV. These studies will take advantage ofthe unique resources
made available by this consortium and ofthe complementary and integrative expertise ofthe Amara and
Pulendran groups, which evaluate novel Env immunogens for the inducfion of neutralizing Abs (NAbs)
(Proiect 1 and Proiect 2). the Ahmed/Silvestri/Crotty group, which explores the regulafion of Ab responses by
T cells (Project 3). and the Cerutti group, which studies the regulafion of B cells by innate immune cells
(Proiect 4). B cells provide immune protecfion against HIV by producing NAbs to envelope (Env) spikes on
the surface ofthe virus. However, elicifing robust and sustained NAb responses remains a major obstacle,
because Env, the only relevant anfigen for NAb inducfion, is characterized by sequence variafion, limited
anfigenicity and scarce immunogenicity. An addifional obstacle relates to the lack of strategies capable of
effectively inducing NAbs both systemically and at mucosal sites of entry. Preliminary data from the Amara
group show that GM-CSF enhances the avidity and frequency of vaccine-induced SIV-reacfive IgG Abs
produced in systemic lymphoid organs and elicits release of SIV-specific IgA in intesfinal secrefions. These
effects correlate with increased protection against an intestinal challenge. In this proposal we hypothesize
that GM-CSF mobilizes and activates a unique subset of splenic IL-21-producing NBH neutrophils equipped
with B cell helper function. We contend that NBH cells enhance systemic IgG and intestinal IgA responses
against SIV by inducing Ig heavy chain class switching, V(D)J gene somafic hypermutafion and gut-homing
receptors in splenic B cells, including marginal zone and memory B cells. Three aims are proposed. Aim 1 is to
elucidate the mechanism by which GM-CSF induces IgG and IgA class switching in splenic B cells. Aim 2 is to
dissect the mechanism by which GM-CSF induces intesfinal homing of splenic IgA class-switched B cells.
Aim 3 is to determine the mechanism by which GM-CSF improves the avidity of vaccine-induced systemic
IgG and intesfinal IgA responses against SIV..
本研究的目的是阐明佐剂GM-CSF增强疫苗诱导的免疫应答的机制。
针对SIV的IgG和伊加应答。这些研究将利用独特的资源
由该财团提供,阿马拉和
Pulendran小组,评估新型Env免疫原诱导中和抗体(NAb)
(项目1和项目2)。Ahmed/Silvestri/Crotty小组,该小组通过以下方式探索Ab反应的调节:
T细胞(项目3)。Cerutti小组研究先天免疫细胞对B细胞的调节
(项目4)。B细胞通过产生NAb包封(Env)刺突来提供针对HIV的免疫保护。
病毒的表面然而,激发强有力和持续的NAb反应仍然是一个主要障碍,
由于Env是NAb诱导的唯一相关抗原,其特征在于序列变异,
缺乏免疫原性。另一个障碍是缺乏能够
有效地诱导NAb的全身和粘膜进入部位。阿马拉号的初步数据
结果表明,GM-CSF增强了疫苗诱导的SIV反应性IgG抗体的亲合力和频率
SIV特异性伊加在肠分泌物中的大量释放。这些
效果与增强对肠道挑战的保护相关。在本提案中,我们假设
GM-CSF动员并激活了一个独特的脾IL-21产生NBH中性粒细胞亚群,
具有B细胞辅助功能。我们认为,NBH细胞增强全身IgG和肠道伊加反应,
通过诱导IG重链类别转换、V(D)J基因体细胞超突变和肠道归巢来抗SIV
受体在脾B细胞,包括边缘区和记忆B细胞。提出了三个目标。目标1:
阐明GM-CSF诱导脾B细胞中IgG和伊加类别转换的机制。目标二是
剖析GM-CSF诱导脾伊加类别转换的B细胞的终末归巢的机制。
目的3:探讨GM-CSF提高疫苗诱导的系统性免疫应答亲和力的机制。
IgG和肠伊加对SIV的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREA CERUTTI其他文献
ANDREA CERUTTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREA CERUTTI', 18)}}的其他基金
Decoding mutualistic microbiota-B cell interactions in the HIV-1-infected gut: impact on immunological non-responders
解码 HIV-1 感染肠道中微生物群与 B 细胞相互作用:对免疫无反应者的影响
- 批准号:
10626870 - 财政年份:2020
- 资助金额:
$ 64.22万 - 项目类别:
Decoding mutualistic microbiota-B cell interactions in the HIV-1-infected gut: impact on immunological non-responders
解码 HIV-1 感染肠道中微生物群与 B 细胞相互作用:对免疫无反应者的影响
- 批准号:
10414937 - 财政年份:2020
- 资助金额:
$ 64.22万 - 项目类别:
Decoding mutualistic microbiota-B cell interactions in the HIV-1-infected gut: impact on immunological non-responders
解码 HIV-1 感染肠道中微生物群与 B 细胞相互作用:对免疫无反应者的影响
- 批准号:
9894545 - 财政年份:2020
- 资助金额:
$ 64.22万 - 项目类别:
Decoding mutualistic microbiota-B cell interactions in the HIV-1-infected gut: impact on immunological non-responders
解码 HIV-1 感染肠道中微生物群与 B 细胞相互作用:对免疫无反应者的影响
- 批准号:
10160898 - 财政年份:2020
- 资助金额:
$ 64.22万 - 项目类别:
Dissecting The Interplay of GM-CSF and Neutrophils In IgG and IgA Responses
剖析 GM-CSF 和中性粒细胞在 IgG 和 IgA 反应中的相互作用
- 批准号:
8516868 - 财政年份:2013
- 资助金额:
$ 64.22万 - 项目类别:
Regulation and Function of Immunoglobulin D in Mucosal Immune Defense
免疫球蛋白 D 在粘膜免疫防御中的调节和功能
- 批准号:
8508845 - 财政年份:2011
- 资助金额:
$ 64.22万 - 项目类别:
Regulation and Function of Immunoglobulin D in Mucosal Immune Defense
免疫球蛋白 D 在粘膜免疫防御中的调节和功能
- 批准号:
8296171 - 财政年份:2011
- 资助金额:
$ 64.22万 - 项目类别:
Regulation and Function of Immunoglobulin D in Mucosal Immune Defense
免疫球蛋白 D 在粘膜免疫防御中的调节和功能
- 批准号:
8180217 - 财政年份:2011
- 资助金额:
$ 64.22万 - 项目类别:
Regulation of antibody diversification and production in HIV-1 infection
HIV-1 感染中抗体多样化和产生的调节
- 批准号:
8050194 - 财政年份:2008
- 资助金额:
$ 64.22万 - 项目类别:
Regulation of antibody diversification and production in HIV-1 infection
HIV-1 感染中抗体多样化和产生的调节
- 批准号:
7586170 - 财政年份:2008
- 资助金额:
$ 64.22万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 64.22万 - 项目类别:














{{item.name}}会员




